申请人:Eli Lilly and Company
公开号:US05010176A1
公开(公告)日:1991-04-23
Modified antibodies or antigen-recognizing fragments are prepared with a linker consisting of a malonate, wherein the antibody or fragment thereof is attached through a carbonyl to an ester or amide group on one of the malonate carboxyls, and the drug is linked through a methylene to the 2-position carbon of the malonate.
修改的抗体或抗原识别片段使用由丙二酸酯组成的连接剂制备,其中抗体或其片段通过羰基连接到丙二酸羧基中的酯或酰胺基团上,药物则通过亚甲基连接到丙二酸酯的2-位碳上。